Efficacy and toxicity of hydroxyurea in mast cell activation syndrome patients refractory to standard medical therapy: retrospective case series

Determine efficacy and adverse events (AEs) of hydroxyurea (HU) in mast cell activation syndrome (MCAS) patients who were refractory to standard medical therapy. An electronic chart review was performed to find MCAS patients who received HU in a MCAS medical practice. Diagnosis of MCAS was establish...

Descripción completa

Detalles Bibliográficos
Autores principales: Weinstock, Leonard B., Brook, Jill B., Molderings, Gerhard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388361/
https://www.ncbi.nlm.nih.gov/pubmed/35982335
http://dx.doi.org/10.1007/s00210-022-02282-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388361/
https://www.ncbi.nlm.nih.gov/pubmed/35982335
http://dx.doi.org/10.1007/s00210-022-02282-8

Ejemplares similares